IP Library Granted Patent US 11,090,432
Granted Patent B2
US 11,090,432 · App. 16/023,505 · Granted Aug 17, 2021

Advanced step therapy delivery for an ambulatory infusion pump and system

Inventors: David DeBelser (Plymouth, MN); Clinton Robert Hetchler (Minnetonka, MN); David Pardee Sours (North Saint Paul, MN); Michael Wade Kersch (Saint Michael, MN)
Assignee: Smiths Medical ASD, Inc.
A61M5/172A61M5/14244A61M5/168G16H20/17G16H40/63A61M2005/14208A61M2205/3334A61M2205/502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,090,432
App. No.
16/023,505
Granted
Aug 17, 2021
Kind
B2
Abstract

Embodiments relate to systems, methods and devices for delivering a drug or other therapy to a patient with an ambulatory infusion pump configured to provide a series of tolerance-building steps leading up to a plateau delivery rate. The plateau delivery rate is maintained until the prescribed amount of drug or therapy fluid is delivered to the patient. Embodiments of the invention include providing the patient or other user with a mechanism to decrease, or step down, the therapy delivery rate if a tolerance was not achieved at a lower rate, and providing notifications prior to a step up in a dosage delivery rate.

Claims (19)

1. An ambulatory infusion pump configured to deliver medicament according to a customized delivery profile that enables a patient to gradually build up a tolerance to the medicament during a therapy session, the ambulatory infusion pump comprising:

a pump control system configured to control operation of a pumping mechanism according to one or more tolerance-building delivery rates defined by a step delivery profile; and

a control module in communication with the pump control system, the control module including a user interface presenting a step delivery profile graphic representing a diagram graphical representation of the step delivery profile, and an indicator graphic illustrating progress along the step delivery profile during the therapy session, wherein a y-axis of the step delivery profile represents a delivery rate of the medicament, and an x-axis of the step delivery profile graphic represents time, wherein the indicator graphic moves along the x-axis of the step delivery profile graphic as the therapy session progresses, and

wherein the ambulatory infusion pump is configured to automatically lengthen a duration of the step delivery profile and of the step delivery profile graphic presented on the user interface along the x-axis upon a scaling back of at least one of the one or more tolerance-building delivery rates in response to a failure to achieve a desired tolerance during the therapy session, and wherein

the user interface is further configured to provide a notification in advance of a transition from a first tolerance-building delivery rate to a second tolerance-building delivery rate,

the notification is configured to prompt the monitoring of a vital sign and/or condition of the patient prior to the transition,

a status of the monitored vital sign and/or condition of the patient prompts the control module to issue a hold dosage flag, and

the hold dosage flag is cleared upon the request for an increase in the tolerance-building delivery rate.

2. An ambulatory infusion pump configured to graphically illustrate progress along a programmed step delivery profile during a therapy session, the ambulatory infusion pump comprising:

a pump control system configured to control operation of a pumping mechanism according to one or more delivery rates defined by the programmed step delivery profile; and

a control module in communication with the pump control system, the control module including a user interface presenting an indicator graphic along with a step delivery profile graphic configured to illustrate progress along the step delivery profile during the therapy session,

wherein the user interface is further configured to provide a notification in advance of a transition from a first tolerance-building delivery rate to a second tolerance-building delivery rate, the notification configured to prompt the monitoring of a vital sign and/or condition of the patient prior to the transition, wherein a status of the monitored vital sign and/or condition of the patient prompts the control module to issue a hold dosage flag, and wherein the hold dosage flag is cleared upon the request for an increase in the tolerance-building delivery rate.

3. The ambulatory infusion pump of claim 2 , wherein the pumping mechanism is configured to dispense medicament for a treatment of at least one of an immune deficiency, inflammation disorder, autoimmune disorder, and/or acute infection.

4. The ambulatory infusion pump of claim 3 , wherein the medicament is an intravenous immunoglobulin (IVIG).

5. The ambulatory infusion pump of claim 2 , wherein the control module enables adjustment of the step delivery profile during the therapy session in response to a failure of a patient to achieve a desired tolerance at any given delivery rate.

6. An ambulatory infusion pump configured to deliver medicament according to a customized delivery profile that enables a patient to gradually build up a tolerance to the medicament during a therapy session, the ambulatory infusion pump comprising:

a pump control system configured to control operation of a pumping mechanism according to one or more tolerance-building delivery rates defined by a step delivery profile; and

a control module in communication with the pump control system, the control module including a user interface presenting an indicator graphic along with a step delivery profile graphic configured to illustrate progress along the step delivery profile during the therapy session,

wherein the user interface is further configured to provide a notification in advance of a transition from a first tolerance-building delivery rate to a second tolerance-building delivery rate, the notification configured to prompt the monitoring of a vital sign and/or condition of the patient prior to the transition, wherein a status of the monitored vital sign and/or condition of the patient prompts the control module to issue a hold dosage flag, and wherein the hold dosage flag is cleared upon the request for an increase in the tolerance-building delivery rate.

Assignments (3)
MERGER Recorded Oct 2, 2024
From: SMITHS MEDICAL ASD, INC.
To: ICU MEDICAL, INC.
Reel/Frame 069101/0767 →
SECURITY AGREEMENT Recorded Aug 16, 2022
From: SMITHS MEDICAL ASD, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 061179/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2018
From: DEBELSER, DAVID; HETCHLER, CLINTON ROBERT; SOURS, DAVID PARDEE; KERSCH, MICHAEL WADE
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 046239/0485 →
Continuity (3)
Continuation 14525579 · Oct 28, 2014
Continuation 12631076 · Dec 4, 2009
Related Publication 20180304010A1 · Oct 25, 2018
Cited By (2)
US 12,233,239 US 12,667,666